Abstract
Published case series and systematic reviews have documented an association between bisphosphonates and osteonecrosis of the jaw. However, a cause-and-effect relationship has not been established, and most of the reported cases have been in patients with cancer who were receiving much higher doses than those used to treat osteoporosis or Paget disease of bone. The risk, if any, to patients with these latter conditions receiving these drugs appears to be very small.
| Original language | English |
|---|---|
| Pages (from-to) | 871-878 |
| Number of pages | 8 |
| Journal | Cleveland Clinic Journal of Medicine |
| Volume | 75 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2008 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver